Atrial Fibrillation
Conditions
Interventions
None listed
Sponsors
National Hospital Organization
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1.The male patients aged over 65 years old at the obtaining informed consent 2.The patients implanted pacemakers over 3 months ago 3.The patients with sinus rhythm at the enrollment 4.The patients implanted atrial pacing lead 5.The patients who have obtained written informed consent after sufficient explanation in advance of participating in this study
Exclusion criteria
Exclusion criteria: 1.Patients presenting shock (systolic blood pressure <90 mmHg) 2.Patients with decompensated heart failure 3.Patients with atrial flutter, atrial tachycardia, permanent atrial fibrillation or long standing atrial fibrillation 4.Patients with bronchiectasis 5.Patients with pancreatic cancer, lung cancer, or colon cancer 6.Patients undergoing chemotherapy or radiation therapy for malignant tumors 7.Patients with severe infections or severe trauma, or within 2 weeks after surgery 8.Patients whose doctors judged them as unsuited to participate in this clinical study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of Atrial Fibrillation | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Exploratory analysis of the patient background 2.The result of the biomaker 3.The ratio of the permanent atrial fibrillation from the paroxysmal atrial fibrillation 4.The incidence of the cardiovascular disease 5.The recurrence of atrial fibrillation after the procedure of pulmonary vein isolation | — |
Countries
Japan
Contacts
Public ContactYoshimi Seki
National Hospital Organization Yokohama Medical Center Clinical Research Department
Outcome results
None listed